TAS0612 elicits the inhibition effect on AKT, p70S6K, and p90RSK and thereby inhibits YBX1 phosphorylation and reverse antiestrogen resistance in breast cancer [32]. This evidence concerns the gene YBX1 and breast carcinoma.